Skip to main content
Smart Investors Daily
TR

NASDAQ · TRHC

Tabula Rasa HealthCare, Inc.

Healthcare · Medical - Healthcare Information Services

$10.50

Up+$0.09 (+0.86%)

Updated Aug 15, 2026, 4:52 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
284.03M
P/E ratio
-3.3
Dividend yield
0.00%
52-week range
— – —
Volume
1.31M
Avg. volume
467.97K

Price performance

TRHC price history

1M range · 0 trading sessions · Daily adjusted prices

TRHC does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest TRHC news

The latest Smart Investors Daily articles mentioning TRHC.

TRHC research

Overview

Company profile and research snapshot.

Company profile

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$3.00
Implied upside
Analysts
TRHC recent ratings
DateFirmRatingTarget
Aug 7, 2023William BlairMarket Perform
May 10, 2023SVB LeerinkOutperform
Nov 7, 2022Piper SandlerNeutral
Aug 18, 2022Piper SandlerNeutral
Aug 8, 2022SVB LeerinkMarket Perform
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Aug 7, 2023

Why Are Tabula Rasa HealthCare Shares Moving Higher Today?

Nautic Partners agreed to acquire Tabula Rasa HealthCare Inc (NASDAQ: TRHC) for $10.50 in cash per share and combine with ExactCare Pharmacy, a portfolio company of Nautic.  The all-cash transaction values Tabula Rasa at approximately $570 million including net debt of approximately $262 million on an enterprise value basis. Following the closing of the transaction, John Figueroa, ExactCare's current Executive Chairman, will assume the role of Chairman and CEO of the combined company. The transaction is expected to close during Q4 of 2023. The deal expands the reach of Tabula Rasa's MedWise technology platform to multiple provider and payer markets. Tabula Rasa HealthCare reported Q2 ...Full story available on Benzinga.com

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.